Nuohui Investment

Nuohui Health develops non-invasive solutions for early cancer screening and home testing. The company offers molecular diagnostic tests, including Changweiqing® for colorectal cancer and Youyou Tube® for Helicobacter pylori detection. This approach makes medical diagnostics accessible and convenient for a wide population via user-friendly, at-home kits.

Established around 2015 by co-founder and CEO Zhu Yeqing and Chairman Yao Naxin, the company identified a critical need for effective, accessible early detection of high-incidence cancers. Their insight was to bridge advanced medical technology with public health, utilizing home-based diagnostics to improve patient outcomes through timely intervention.

Nuohui Health serves the general public, empowering individuals with convenient tools for proactive health management and early disease detection. The company envisions leading the accessible early cancer screening market, continually expanding its offerings to cover more cancers and facilitate timely intervention for improved outcomes.